Medicine

Human biology is the research focus of a number of EPFL labs, where scientists conduct clinical trials with volunteers to design therapeutic interventions and to learn more about how the body functions. Here, we take a closer look at the work of Prof. Friedhelm Hummel, who is developing therapies for stroke survivors.

ETH researchers have used computer simulations to show that tissue structure in different types of cancer is decisive in determining how a tumour develops. This information could make it possible to treat patients in a more targeted manner in future.

Those who have just undergone surgery in the hospital, with their weakened immune systems, are easy prey for pathogens that lurk on a wide variety of surfaces. Even careful disinfection can only partially prevent these hospital-acquired infections. One hope in the fight against the pathogenic bacteria are bacteriophages. Eawag researchers were able to show that they improve the removal of pathogens from surfaces, especially in combination with chemical disinfection.

A team of researchers led by Professor Yimon Aye at EPFL’s School of Basic Sciences has developed a new screening method to explore an important biological process known as electrophile signaling.

EPFL scientists have made the first link between muscular dystrophy and a group of bioactive fats, the sphingolipids, which are involved in numerous cell functions and other diseases.

PSI is involved in the development of a breath test that can be used to diagnose asthma. Imad El Haddad explains why such a test could be extremely useful – especially for children.